437 results on '"Wraith, David C"'
Search Results
52. Avidity and the Art of Self Non-Self Discrimination
53. Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP1–10 covalently bound to the MHC class II molecule I-Au
54. Complete characterization of the expressed immune response genes in Biozzi AB/H mice: structural and functional identity between AB/H and NOD A region molecules
55. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein
56. Regulatory CD4 + T cells and the control of autoimmune disease
57. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire
58. A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease
59. T-cell receptor degeneracy: the dog that did not bark: Adaptation of the self-reactive T-cell response to limit autoimmune disease
60. Natural and Induced Regulatory T Cells
61. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in Th1 and Th2 cells
62. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia
63. TUNING THE PERIPHERAL IMMUNE RESPONSE TO ANTIGEN.
64. USING ALTERED PEPTIDE LIGANDS TO ASSESS THE LIMITS OF T-CELL PROMISCUITY
65. Differential Nr4a1 and Nr4a3 expression discriminates tonic from activated TCR signalling events in vivo
66. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
67. A humanized HLA-DR4 mouse model for autoimmune myocarditis
68. Protein kinase C theta is required for efficient induction of IL-10-secreting T cells
69. Immunotherapy With Apitopes Blocks the Immune Response to TSH Receptor in HLA-DR Transgenic Mice
70. Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
71. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
72. Designing antigens for the prevention and treatment of autoimmune diseases
73. The Future of Immunotherapy: A 20-Year Perspective
74. Author response: Variant proteins stimulate more IgM+ GC B-cells revealing a mechanism of cross-reactive recognition by antibody memory
75. Myeloid‐derived suppressor cells mediate tolerance induction in autoimmune disease
76. Glycogen synthase kinase-3 controls IL-10 expression in CD4+ effector T-cell subsets through epigenetic modification of the IL-10 promoter
77. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
78. Tr1-Like T Cells – An Enigmatic Regulatory T Cell Lineage
79. CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine
80. Cytotoxic T-cell recognition of influenza-infected target cells varies in different H-2 k mouse strains
81. Dk-restricted antiinfluenza cytotoxic t-cell clone loses one of its two alloreactivities
82. Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
83. Glycogen synthase kinase‐3 controls IL‐10 expression in CD4+ effector T‐cell subsets through epigenetic modification of the IL‐10 promoter
84. Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy
85. Blockade of LFA-1 augments in vitro differentiation of antigen-induced Foxp3+ Treg cells
86. Control of autoimmune neuroinflammation by nanoparticle-based myelin-antigen delivery to liver sinusoidal endothelial cells
87. Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis
88. CD86 Has Sustained Costimulatory Effects on CD8 T Cells1
89. A hazardous vapour trail from abattoir to neuropathy clinic
90. CTLA-4 Modulates the Differentiation of Inducible Foxp3+ Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
91. TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
92. Author response: Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy
93. New inhibitory signaling by CTLA-4
94. Modification of the FoxP3 Transcription Factor Principally Affects Inducible T Regulatory Cells in a Model of Experimental Autoimmune Encephalomyelitis
95. Regulation of Adaptive Immunity; The Role of Interleukin-10
96. CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire
97. Comment on “Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells”
98. Antigenic strength controls the generation of antigen‐specific IL‐10‐secreting T regulatory cells
99. Isolation and characterization of human interleukin-10–secreting T cells from peripheral blood
100. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.